Experimental and translational studies suggest that elevated prolactin levels contribute to obesity-related phenotypes through multiple pathways, including altered central appetite regulation, modulation of adipocyte differentiation and lipid storage, impairment of insulin sensitivity, and disruption of the hypothalamicpituitarygonadal (HPG) axis
The extracted data included characteristics of the study cohort, study design, details of specific interventions (drugs and dosing) and pharmacokinetic outcomes
This product is not a drug, food, or cosmetic
September 15, 2025: Maryland Government Reviewing Cost Concerns for Trulicity, Other Diabetes Medications Marylands Prescription Drug Affordability Board is reviewing the cost of six diabetes and weight loss management medications, including Trulicity
Underlying health conditions can also lead to low B12 levels